Market Tracker

10/23 2:32pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

109.42
Real-Time Quote
 +3.25 / +3.06%
Today’s Change
58.06
Today|||52-Week Range
116.88
+47.27%
Year-to-Date

Today’s Trading

Previous close106.17
Today’s open107.03
Day’s range106.33 - 109.44
Volume659,439
Average volume (3 months)1,658,741
Market cap$25.8B
Dividend yield--
Data as of 2:17pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-43.20%
Earnings growth (next 5 years)+159.50%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book18.64

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+5.05+3.36%
MYLMylan Inc+0.59+1.17%
ZTSZoetis Inc+0.42+1.17%
ALXNAlexion Pharmaceutic...+11.93+6.89%
Data as of 2:32pm ET, 10/23/2014

Financials

Next reporting dateOctober 27, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts